2025 annual financial data
Cadrenal Therapeutics 2025 Operating margin
Cadrenal Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -13,461,177 USD and net income was -13,237,362 USD.
Operating cash flow was -12,601,666 USD.
Get free Cadrenal Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,461,177 USD
- Net income
- -13,237,362 USD
- Operating cash flow
- -12,601,666 USD